regseeds
Well-known member
https://www.wsj.com/articles/jazz-pharmaceuticals-to-buy-cannabis-based-drugmaker-gw-pharma-for-6-7-billion-11612370417?mod=e2tw
“We saw an opportunity to add near-term what we think is a blockbuster product in Epidiolex, as well as bring in a pipeline engineered around cannabinoids in neuroscience,” Mr. Cozadd said.
“We saw an opportunity to add near-term what we think is a blockbuster product in Epidiolex, as well as bring in a pipeline engineered around cannabinoids in neuroscience,” Mr. Cozadd said.
